116.80CHF+0.78%Mkt Cap: 222.87B CHFP/E: 21.51Last update: 2026-05-13
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.51
P/E (Forward)15.31
PEG2.62
P/B6.14
P/S3.94
EV/EBITDA11.48
EV/Revenue4.65
EPS (TTM)5.46
EPS (Forward)7.62
Cash Flow & Leverage
FCF Yield5.40%
FCF Margin21.25%
Operating CF19.14B CHF
CapEx (TTM)3.90B CHF
Net Debt/EBITDA1.75
Net Debt40.11B CHF
Technical
SMA 50118.30 (-1.3%)
SMA 200110.81 (+5.4%)
Beta0.49
S&P 52W Chg24.23%
Avg Vol (30d)2.45M
Avg Vol (10d)2.31M
Technical Indicators
RSI (14)51.1
MACD-1.2047
MACD Signal-1.5322
MACD Hist.+0.3275
BB Upper119.06 CHF
BB Middle115.43 CHF
BB Lower111.80 CHF
BB Width6.29%
ATR (14)2.413 CHF
Vol Ratio (20d)0.90x
52W Range
87.8967% of range131.00
52W High131.00 CHF
52W Low87.89 CHF
Profitability
Gross Margin75.83%
EBITDA Margin40.51%
Profit Margin24.67%
Oper. Margin30.48%
ROE30.31%
ROA12.60%
Revenue Growth-0.70%
Earnings Growth-9.30%
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh19.02 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate3.700 CHF
Trail. Div Rate4.666 CHF
Div. Yield3.17%
5Y Avg Yield3.60%
Payout Ratio66.26%
Ex-Div DateMar 10, 2026
Pay DateMar 13, 2025
Splits
Last Split6:5
Split DateOct 4, 2023
Ownership
Shares Out.1.91B
Float1.82B
Insiders2.11%
Institutions44.85%
Analyst Consensus
Rating2.6 (Hold)
Target (Mean)122.13 CHF
Target Range95.16 CHF – 140.24 CHF
# Analysts21
Company
Market Cap222.87B CHF
Enterprise Value263.16B CHF
Revenue (TTM)56.58B CHF
Gross Profit42.98B CHF
Net Income (TTM)13.98B CHF
Revenue/Share29.40 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
Last Price116.80 CHF
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267